5-(Difluoromethoxy)-2-nitro-toluene, 250mg

(1R,3S,E)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5S,E)-5-Cyclopropyl-5-hydroxypent-3-en-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol, 98%, 5g

Methyl 6-nitro-1H-indazole-3-carboxylate, 95.0%, 250mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-methyl-3-(tritylthio)butanoic acid, 97%, 10g

6-Fluorobenzo[e][1,2,3]oxathiazine 2,2-dioxide, 98%, 250mg

1'-methylspiro[piperidine-3,3'-pyrrolo[3,2-b]pyridin]-2'(1'H)-one dihydrochloride, 95.0%, 250mg

Methyl 2-methoxy-5-nitrobenzoate, 95.0%, 10g

1-Decanesulfonic acid, sodium salt, 98.0%, 500g

3-(2-methyl-1H-imidazol-1-yl)propanoic acid hydrochloride, 95.0%, 2.5g

o-Anisidine , >=98 %, pour la synthèse, 2,5 L, emballage en verre

2-Chloro-6-hydroxybenzoic acid, 95.0%, 1g

2,4,6-Trihydroxybenzoic acid hydrate, 95.0%, 25g

((2R,3R,5R)-3-(benzoyloxy)-4,4-difluoro-5-((methylsulfonyl)oxy)tetrahydrofuran-2-yl)methyl benzoate, 97%, 1g